Home Authors Posts by Chris Janiec

Chris Janiec

Chris Janiec is Americas Editor at Agri Investor. Based in New York, Janiec coordinates coverage of private investment into global food and agriculture with colleagues in London. Previously, Janiec covered non-bank capital markets for PEI’s Private Debt Investor, taught international relations and US foreign policy at China Foreign Affairs University in Beijing and worked as an analyst of petroleum and shipping markets in New York.
CEO Ejnar Knudsen says Devil Mountain Wholesale Nursery is the third recent divestment of a Fund II business, reflecting an active stance among strategic investors.
US row crop revenue growth depends on the country’s ability to tap new export markets in a time of growing competition from the Black Sea and LatAm, while reducing a reliance on Chinese buyers.
Ecosystem Investment Partners is raising $650m for its latest environmental restoration strategy that targets wetlands, streams and endangered species habitats.
Arkansas' ESG Oversight Committee has the power to force the state's Teacher Retirement System to divest from private investment funds managed by GPs deemed to be discriminating against companies on ESG grounds.
Managing partner Katrin Burt says the round is designed to help Colorado-headquartered Meati capitalize on a taste and nutrition advantage that could make it a category leader.
Managing partner Phil Erlanger says a pivot away from ag by large investors has helped bring the remaining specialists like Aliment into a ‘more proprietary’ position.
Eucaliptus trees, forestry, timberland
Gerrity Lansing says positive investor sentiment around Latin America has returned to a level last seen around 2015, when the firm closed BTF I on $860m.
Unifrutti chief executive Mohamed Elsarky says the global fresh fruit platform being built in part to strengthen the UAE's ‘food resilience’ is all about establishing scale.
David Gould, FarmTogether
David Gould says his move from agribusiness to farmland comes at a time when interest rates and stress in other sectors is starting to bring investors’ attention to real assets.
The biological inputs pioneer has been sold for parts after failing to raise further capital, but it was still considered an important strategic acquirer as recently as September 2021.

Copyright PEI Media

Not for publication, email or dissemination